Recognition of Chlamydia trachomatis by Toll-like receptor 9 is altered during persistence

被引:0
|
作者
Diallo, Aissata [1 ,2 ]
Overman, Grace [1 ,2 ]
Sah, Prakash [1 ,2 ]
Liechti, George W. [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA
[2] Henry Jackson Fdn Adv Mil Med, Bethesda, MD USA
关键词
Chlamydia; innate immunity; TLR9; pathoadaptation; persistence; OUTER-MEMBRANE PROTEIN; IN-VITRO; PROTECTIVE IMMUNITY; GENE-TRANSFER; CELL BIOLOGY; TLR9; DNA; INFECTION; MURIDARUM; MACROPHAGES;
D O I
10.1128/iai.00063-24
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptor 9 (TLR9) is an innate immune receptor that localizes to endosomes in antigen presenting cells and recognizes single stranded unmethylated CpG sites on bacterial genomic DNA (gDNA). Previous bioinformatic studies have demonstrated that the genome of the human pathogen Chlamydia trachomatis contains TLR9 stimulatory motifs, and correlative studies have implied a link between human TLR9 (hTLR9) genotype variants and susceptibility to infection. Here, we present our evaluation of the stimulatory potential of C. trachomatis gDNA and its recognition by hTLR9- and murine TLR9 (mTLR9)-expressing cells. Utilizing reporter cell lines, we demonstrate that purified gDNA from C. trachomatis can stimulate hTLR9 signaling, albeit at lower levels than gDNA prepared from other Gram-negative bacteria. Interestingly, we found that while C. trachomatis is capable of signaling through hTLR9 and mTLR9 during live infections in HEK293 reporter cell lines, signaling only occurs at later developmental time points. Chlamydia-specific induction of hTLR9 is blocked when protein synthesis is inhibited prior to the RB-to-EB conversion, exacerbated by the inhibition of lipooligosaccharide biosynthesis, and is significantly altered during the induction of aberrance/persistence. Our observations support the hypothesis that chlamydial gDNA is released during the conversion between the pathogen's replicative and infectious forms and during treatment with antibiotics targeting peptidoglycan assembly. Given that C. trachomatis inclusions do not co-localize with TLR9-containing vacuoles in the pro-monocytic cell line U937, our findings also hint that chlamydial gDNA is capable of egress from the inclusion, and traffics to TLR9-containing vacuoles via an as yet unknown pathway.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] The role of Toll-like receptor 9 in gynecologic cancer
    Fehri, E.
    Ennaifer, E.
    Rhouma, R. Bel Haj
    Guizani-Tabbane, L.
    Guizani, I.
    Boubaker, S.
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2016, 64 (03) : 155 - 159
  • [32] Toll-like Receptor 9, What O'Clock Is It?
    Obermann, Hannah-Lena
    Bauer, Stefan
    IMMUNITY, 2012, 36 (02) : 159 - 161
  • [33] Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
    Kang, Jin Young
    Nan, Xuehua
    Jin, Mi Sun
    Youn, Suk-Jun
    Ryu, Young Hee
    Mah, Shinjee
    Han, Seung Hyun
    Lee, Hayyoung
    Paik, Sang-Gi
    Lee, Jie-Oh
    IMMUNITY, 2009, 31 (06) : 873 - 884
  • [34] A Novel Toll-Like Receptor 9 Signaling in Cardiomyocytes
    Shintani, Yasunori
    Kapoor, Amar
    Drexler, Hannes
    Terracciano, Cesare
    Smolenski, Ryszard
    Kaneko, Masahiro
    Harada, Narumi
    Coppen, Steven
    Narita, Takuya
    Campbell, Niall
    Ikebe, Chiho
    Thiemermann, Chris
    Yashiro, Kenta
    Suzuki, Ken
    CIRCULATION, 2011, 124 (21)
  • [35] Regulation and function of toll-like receptor 9 in macrophages
    Sweet, Matthew J.
    Schroder, Kate
    Sester, David P.
    Trieu, Angela
    Rehli, Michael
    Risvanathan, Kumar
    Stacey, Katryn J.
    Hume, David A.
    INFLAMMATION RESEARCH, 2005, 54 : S186 - S186
  • [36] Therapeutic potential of Toll-like receptor 9 activation
    Krieg, Arthur M.
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) : 471 - 484
  • [37] Toll-like receptor 9 agonists as cancer therapeutics
    Holtick, Udo
    Scheulen, Max E.
    von Bergwelt-Baildon, Michael S.
    Weihrauch, Martin R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (03) : 361 - 372
  • [38] TOLL-LIKE RECEPTOR 9 IN TRAUMA-HEMORRHAGE
    Zhang, X.
    Gao, M.
    Yu, H.
    Lu, C.
    Ha, T.
    Williams, D. L.
    Li, C.
    Kao, R.
    SHOCK, 2011, 35 : 41 - 41
  • [39] Cloning and characterization of equine Toll-like receptor 9
    Zhang, Yuwen
    Davis, Elizabeth G.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [40] Toll-like receptors involved in the response to microbial pathogens: Development of agonists for toll-like receptor 9
    Schetter, C
    Vollmer, J
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (02) : 204 - 210